Uroloxía
Servizo
Juan
Morote Robles
Publicacións nas que colabora con Juan Morote Robles (10)
2020
-
Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry
Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 156-163
2017
-
Consenso sobre el manejo del cáncer de próstata resistente a la castración avanzado en España
Archivos Espanoles de Urologia, Vol. 70, Núm. 9, pp. 777-791
2016
-
Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer
Critical Reviews in Oncology/Hematology, Vol. 100, pp. 127-136
2015
-
The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy
Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969
2013
-
Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition
Actas Urologicas Espanolas
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2012
-
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial
The Lancet, Vol. 379, Núm. 9810, pp. 39-46
2011
-
Prostate cancer in Spain: From guidelines to clinical practice
BJU International, Vol. 108, Núm. 1, pp. 61-66
2007
-
Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates
Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 12, Núm. 4, pp. 13
2005
-
Cáncer de próstata de alto riesgo y diseminado (Documento de Consenso de Recomendaciones)
Actas Urologicas Espanolas, Vol. 29, Núm. 9, pp. 826-827